Loss of the regulation in protein tyrosine phosphorylation has been implicated in many diseases, including cancer, diabetes, and autoimmune disorders, suggesting that PTPs may act as potential drug targets [1,2]. The gene discussed is PTS; the disease is diabetes mellitus.